|
|
|
LifeScienceHistory.com - Check us out on Instagram
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
AutoGenomics, Inc.
| | | Phone: | (760) 477-2251 | Fax: | (760) 477-2252 | Year Established: | 1999 | Main Contact: | Jim Canfield, CCO | | Other Contacts: | Saeed Kureshy, VP, Operations Evelyn Lopez, VP, Regulatory Affairs Shelley Singh, Ph.D., Co-founder, VP, System Development Robert B. Cole, M.D., CMO Ramanath Vairavan, Co-founder, Senior VP, Laboratory Operations Fareed Kureshy, Founder, Chairman, President and CEO
| | Company Description | AutoGenomics is a privately held company that has developed the first automated, microarray based multiplexing diagnostic platform that can be used to assess disease signatures with novel genomic and proteomic markers. AutoGenomics’ molecular diagnostics proprietary technology platform is in use globally in clinical reference laboratories, contract research organizations (CRO’s), specialty clinics and hospital laboratories. The platform consists of a family of INFINITI® analyzers including the INFINITI® PLUS, a prepared sample to answer system, and the INFINITI® High Throughput System, which has the capability of producing over 6,000 patient results per day. The platform also includes five US FDA cleared tests and a menu of over 65 genetic tests for potential application in the areas of personalized medicine (pain management, cardiovascular health assessment and mental health therapy), women’s health, oncology, infectious diseases and genetic disorders. With the discovery of genes and their link to various disease states, the platform has the versatility to revolutionize the way patients are diagnosed, monitored and managed, leading to the era of precision medicine. | |
|
|
|
|
|